VulnerabilityModified
CVE-2022-2143
The affected product is vulnerable to two instances of command injection, which may allow an attacker to remotely execute arbitrary code.
CRITICAL 9.8EPSS 59.4%
Does this matter?
EPSS puts the probability of exploitation in the next 30 days at 59.4%, higher than 99% of all known CVEs. Patch or mitigate before the next change window.
Description
The affected product is vulnerable to two instances of command injection, which may allow an attacker to remotely execute arbitrary code.
- CVSS 3.1
- 9.8 CRITICALCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 59.41% probability · 99th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-77
- Affected
- advantech/iview
- Source
- ics-cert@hq.dhs.gov
References
- http://packetstormsecurity.com/files/168108/Advantech-iView-NetworkServlet-Command-Injection.htmlExploit, Third Party Advisory, VDB Entry
- https://www.cisa.gov/uscert/ics/advisories/icsa-22-179-03Third Party Advisory, US Government Resource
- http://packetstormsecurity.com/files/168108/Advantech-iView-NetworkServlet-Command-Injection.htmlExploit, Third Party Advisory, VDB Entry
- https://www.cisa.gov/uscert/ics/advisories/icsa-22-179-03Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.